Compared with the survivor group, the non-survivor group had a significantly lower performance status score and hemoglobin and albumin levels; higher incidence of comorbidities, such as chronic kidney diseases, heart failure, and hepatic diseases, and respiratory failure; and greater C-reactive protein (CRP) levels, as shown in Table 1. This evidence concerns the gene CRP and chronic kidney disease.